arrow_back Back Filing freshness 20-F FY 2026 SEC EDGAR

download Export Data

Akso Health Group

AHG

$1.29 ▼ -0.04 (-2.63%) at close

12 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Akso Health Group faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $2.8B

Dividend Yield —

Revenue Growth -6.4% ↘

Op. Margin -149.7%

ROIC -10.3% ↗

FCF / Share $-0.01 ↘

Trailing P/E 129.0x

Price / Book 15.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$13.83M

↓ -6.4% —

Net Income Profit after all expenses

$-18.67M

↑ +86.2% —

Operating Margin Operating profit as % of sales

-149.7%

↑ +58.2% 0th

FCF / Share Free cash flow per share

$-0.01

↓ -593.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.40 Latest / share

FY 2015

FY 2016

FY 2017

$0.40

FY 2018

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

FY 2026

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Apr 15, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Jul 23, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗	FY 2015 Mar 31, 2015 20-F ↗
Revenue Growth YoY (%)	-6.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-228%)	512.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10142%)	-81.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1734%)	108.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2077%)	259.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5092%)	-84.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1793%)	-81.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1727%)	-42.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-956%)	—	—	—	—
EPS Growth YoY (%)	-93.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-250.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	92.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	60.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	51.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-92.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	630.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	150.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	86.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-1327.0% Weak ↓ Weak Declining Year-over-year change in net income	-595.5% Weak ↓ Weak Declining Year-over-year change in net income	91.9% Excellent ↑ Excellent Improving Year-over-year change in net income	51.6% Excellent ↑ Excellent Improving Year-over-year change in net income	51.1% Excellent ↓ Excellent Declining Year-over-year change in net income	N/M	-91.6% Weak ↓ Weak Declining Year-over-year change in net income	664.0% Excellent Excellent Year-over-year change in net income	142.2% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	-87.5% Weak Weak Year-over-year change in free cash flow	N/M	67.2% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	-3123.0% Weak ↓ Weak Declining Year-over-year change in free cash flow	N/M	908.1% Excellent Excellent Year-over-year change in free cash flow	15.9% Good Good Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	1.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	32.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	11.2% Good ↑ Good Improving Compound annual revenue growth over 3 years	4.9% Caution ↑ Caution Improving Compound annual revenue growth over 3 years	-53.1% Weak Weak Compound annual revenue growth over 3 years	-74.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—
Revenue CAGR 5Y (%)	51.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	5.3% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-47.6% Weak Weak Compound annual revenue growth over 5 years	-34.2% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	—	—	11.2% Good Good Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Apr 15, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Jul 23, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗	FY 2015 Mar 31, 2015 20-F ↗
Operating Margin (%) (%)	-149.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1347%)	—	-357.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3082%)	-108.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1002%)	-252.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2204%)	—	—	8.3% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-31%)	70.7% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+490%)	—	—	—
Effective Tax Rate (%) (%)	9.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.5% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	25.3% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	14.4% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.1% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.1% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-135.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1787%)	—	-391.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4997%)	-10.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-229%)	-267.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3438%)	—	—	9.0% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+13%)	61.1% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+663%)	—	—	—
FCF Margin (%) (%)	-92.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	6.9% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	56.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-24.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-136.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-488.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-2.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	81.8% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.39x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.34x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.99x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Apr 15, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Jul 23, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗	FY 2015 Mar 31, 2015 20-F ↗
Return on Invested Capital (%)	-10.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-68.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-163.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-130.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-181.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-151.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	46.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	35.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-77.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-31.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-97.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-87.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	46.3% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	34.9% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-10.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-67.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-552%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-15.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-137.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1015%)	-201.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1444%)	-148.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1087%)	4.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-71%)	46.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+212%)	36.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+143%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Apr 15, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Jul 23, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗	FY 2015 Mar 31, 2015 20-F ↗
Interest Coverage (x)	—	—	-77.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-42.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-23.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	-14.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-170.57K	$-176.23M	$-85.17M	$-7.92M	$-21.93M	$-15.13M	$-10.93M	$-57.37M	$-132.62M	$-19.23M	$-7.82M	$-954.68K

📊 What does each share earn? 8 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Apr 15, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Jul 23, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗	FY 2015 Mar 31, 2015 20-F ↗
Revenue per Share (USD)	$0.01	$0.02	$0.02	$0.19	$0.11	$0.04	$0.23	$1.26	$2.38	—	—	—
Basic EPS, GAAP (USD)	$0.01	$0.16	$-0.07	$-0.02	$-0.28	$-0.71	$-1.46	$0.11	$1.46	$0.20	$0.08	—
Free Cash Flow per Share (USD)	$-0.01	$0.00	$0.01	$-0.05	$-0.14	$0.21	$-1.15	$-0.04	$1.95	$0.19	$0.17	—
Dividend per Share (USD)	—	—	—	—	—	—	—	—	$0.40	—	—	—
Book Value per Share (USD)	$0.08	$0.23	$0.32	$0.13	$0.18	$0.35	$0.99	$2.57	$2.92	$0.55	—	—
Tangible Book Value per Share (USD)	$0.08	$0.21	$0.20	$0.13	$0.18	$0.35	$0.99	$2.57	$2.92	$0.55	—	—
Basic Weighted Avg Shares (shares)	2.17B	855.29M	141.52M	68.60M	59.61M	48.84M	48.76M	48.69M	44.98M	42.33M	42.08M	—
Dividend Payout Ratio (%)	—	—	—	—	—	—	—	—	27.4% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Apr 15, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Jul 23, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗	FY 2015 Mar 31, 2015 20-F ↗
Working Capital (USD)	$180.84M	$182.31M	$138.42M	$8.84M	$12.23M	$15.71M	$39.75M	$71.12M	$139.28M	—	—	—
Total Equity (USD)	$180.93M	$199.12M	$138.37M	$8.73M	$12.28M	$17.27M	$48.10M	$126.50M	$140.04M	$23.50M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Mar 31, 2026 20-F ↗	FY 2025 Mar 31, 2025 20-F ↗	FY 2024 Apr 15, 2024 20-F ↗	FY 2023 Mar 31, 2023 20-F ↗	FY 2022 Mar 31, 2022 20-F ↗	FY 2021 Mar 31, 2021 20-F ↗	FY 2020 Mar 31, 2020 20-F ↗	FY 2019 Mar 31, 2019 20-F ↗	FY 2018 Jul 23, 2018 20-F ↗	FY 2017 Mar 31, 2017 20-F ↗	FY 2016 Mar 31, 2016 20-F ↗	FY 2015 Mar 31, 2015 20-F ↗
Sales/Revenue/Turnover (USD)	$13.83M	$14.78M	$2.41M	$13.18M	$6.31M	$1.75M	$11.44M	$61.33M	$107.26M	—	—	—
Depreciation Expense (USD)	$6.74K	$1.62K	—	—	$18.39K	$15.16K	$580.50K	$406.80K	$174.38K	$92.22K	$61.39K	—
Net Income, GAAP (USD)	$-18.67M	$-134.98M	$-9.46M	$-1.36M	$-16.85M	$-34.83M	$-71.20M	$5.53M	$65.48M	$8.57M	$3.54M	—
Operating Cash Flow (USD)	$-12.79M	$1.18M	$1.35M	$-3.25M	$-8.63M	$10.06M	$-55.87M	$-1.73M	$87.72M	$8.19M	$7.03M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 12 years · 12 quarters

Akso Health Group

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AHG with peers